Serologicals Corporation Implements Accelerated Integration Program for Research Segment

Serologicals Corporation today announced that it has begun the implementation of an accelerated integration program for its research segment as outlined in its announcement on June 21, 2005. This program includes the integration of several core functions, including Business Segment Management, R&D/Business Development, Marketing, Technical Support, Scientific Sourcing, Intellectual Property/Licensing and Finance and Accounting. The company expects to achieve operating efficiencies that should result in annual savings of $3.0 million to $3.5 million. "This represents a significant step in the integration of our Upstate and Chemicon units that will enable the company to further improve our high level of customer focus, development and support while enabling us to improve the day-to-day efficiency of the organization," said David A. Dodd, President and Chief Executive Officer of Serologicals


Serologicals Corporation Implements Accelerated Integration Program for Research Segment

BioBOOM Op/Ed: More market consolidation affects and sadly more lost jobs too. Another reflection on poor planning because it can't just be the market since others are growing.

No comments:

Blog Archive